Rociverine combined with tamsulosin in treatment of overactive bladder after transurethral resection of prostate
10.3760/cma.j.issn.1674-6090.2013.04.020
- VernacularTitle:罗西维林联合坦索罗辛治疗经尿道前列腺电切术后膀胱过度活动症
- Author:
Cheng LIU
;
Jiagui MU
;
Duo LIU
;
Xuejun LIU
;
Kai LU
;
Yansheng REN
;
Dongsheng ZHU
- Publication Type:Journal Article
- Keywords:
Rociverine;
Tamsulosin;
Overactive bladder;
TURP
- From:Journal of Endocrine Surgery
2013;7(4):319-321
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the efficacy and safety of rociverine combined with tamsulosin in treatment of overactive bladder after transurethral resection of prostate (TURP).Methods 93 cases of overactive bladder patients who received TURP were collected.They were given rociverine tablets 10 mg 3 times a day and tamsulosin 0.2 mg once a day for 7 to 10 days.The efficacy and safety of treatment were assessed by changes before and after treatment in subjective indicators of overactive bladder syndrome score(OABSS),the international prostate symptom score(IPSS) and quality of life score(QOL) and objective indicators including daily frequency of micturition,urgency,urgency incontinence,nocturia,voiding volumes,combining with the adverse drug reaction incidence.Results The average treating time for the 93 cases was (5 ± 3) days.The average score of OABSS reduced 8.12(P ＜0.01,and each score≤ 4).The average score of IPSS reduced 16.69(P ＜0.01).The average score of QOL reduced 2.18 (P ＜ 0.01).There was statistical difference in objective indicators of patients between before and after treatment(P ＜ O.05).The adverse drug reaction incidence was 2.1％ (2 cases with thirsty symptom).Conclusion Rociverine tablets combined with tamsulosin in treatment of patients with overactive bladder after TURP are effective and safe.
